Document is current

Any future updates will be listed below

Argininosuccinate Synthetase-1 (ASS1) Loss in High-Grade Neuroendocrine Carcinomas of the Urinary Bladder: Implications for Targeted Therapy with ADI-PEG 20

Crossref DOI link: https://doi.org/10.1007/s12022-018-9516-9

Published Online: 2018-02-16

Published Print: 2018-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark